Jade Biosciences, Inc. Common Stock JBIO Cash Flow Statement
| TTM Q1 '26 | TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | ||
|---|---|---|---|---|---|---|
| -$129.61M-1.7% | -$127.41M+10.6% | -$142.46M-6.7% | -$133.56M-30.9% | -$102.02M-17.2% | ||
| $31K+19.2% | $26K+4.0% | $25K-89.2% | $231K-10.5% | $258K-8.5% | ||
| $24.99M+24.9% | $20.01M+68.6% | $11.87M+56.2% | $7.6M+0.4% | $7.57M-19.0% | ||
| -$100.01M-5.6% | -$94.69M-13.2% | -$83.65M-22.4% | -$68.33M-41.8% | -$48.17M+9.3% | ||
| —— | $196K— | —— | —— | —— | ||
| -$268.33M-8.6% | -$247.01M-82.0% | -$135.72M-1,145% | $12.99M-50.0% | $25.98M+18.3% | ||
| $360.67M0.0% | $360.77M+27.7% | $282.61M-25.1% | $377.38M+103% | $186.07M-0.6% | ||
| $5.16M-72.9% | $19.05M-62.0% | $50.11M-83.8% | $308.91M+124% | $137.9M-3.6% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Jade Biosciences, Inc. Common Stock generate?
- Jade Biosciences, Inc. Common Stock (JBIO) generated -$100.0M in operating cash flow over the trailing twelve months.
- What is Jade Biosciences, Inc. Common Stock's free cash flow?
- After $196.0K of capital expenditures, Jade Biosciences, Inc. Common Stock's free cash flow was -$94.9M over the trailing twelve months, down 66.7% year over year.
- Where does Jade Biosciences, Inc. Common Stock's cash flow data come from?
- Every line is extracted from Jade Biosciences, Inc. Common Stock's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.